TASE: TGTR
2.00
-2.39%
₪34,711,214.93
200.10
Update On: 10:15 2026/09/07
About Together
Together Pharma is an Israeli medical cannabis company with an integrated operating platform spanning cultivation, production, quality assurance, product development, marketing and commercial distribution.
With operations in Israel and Uganda, strict quality certifications, and strategic European partnerships, Together Pharma is positioned to leverage its operational scale, cost structure, and expanding product portfolio in the global medical cannabis market.
Key Highlights
Together Pharma combines financial momentum with a fully integrated operating platform, broad distribution access and international growth infrastructure.
NIS 109.6M
Record 2025 revenue, demonstrating continued commercial growth.
NIS 22.8M
Strong operational performance and an improving profitability profile.
NIS 15.2M
Operating profit, marking a significant increase compared with 2024.
NIS 50.1M
Shareholders' equity and a strengthened financial position.
500+
Pharmacy points of sale across the Israeli medical cannabis market.
59 Dunams
Cultivation footprint across Israel and active greenhouses in Uganda.
Immediate Reports
July 13, 2026
Update Regarding the Medical Cannabis Unit’s Notice at the Ministry of Health
May 6, 2026
Development of an inhaler for administering medical cannabis treatment in a measured dose
January 8, 2026
Update Regarding the Withdrawal of an Application for Approval of a Distribution Under Section 303 of the Companies Law
From The Press
March 26, 2026
Funder: Breakthrough Year for Together Pharma – Operating Profit Surges 365%, Record Revenue Reaches NIS 110 Million
February 28, 2026
Your Highness × Together Pharma Bring West Coast Genetics to Tel Aviv
February 25, 2025
The Marker: Together’s share jumps on the stock exchange following expectations of a significant increase in revenue.
Investor Mail Alerts
Receive company updates and investor news by email.